https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-initiates-dosing-phase-12-study-aro
https://www.businesswire.com/news/home/20200811005244/en/Arrowhead-Pharmaceuticals-Initiates-Dosing-Phase-12-Study
Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis
Aug 11, 2020 at 7:30 AM EDT
